What if CAR T cells, revolutionary cancer fighters normally manufactured in the lab, could be created inside the patient? This quest to simplify CAR T therapy has brought two biotech companies to a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Shorla Oncology (‘Shorla’), a US-Ireland pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved the company’s oncology ...
The Chosun Ilbo on MSN
In vivo CAR-T offers single-injection cancer treatment hope
Will a world where cancer is treated with a single injection arrive? The so-called ‘in vivo CAR-T’ method, which directly alters immune cells within the body, is recently transforming the cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results